Abstract Renal injury due to ischaemia/reperfusion (I/R) leads to impaired renal function. One of the essential pathological changes thereby is cell death due to apoptosis. This study investigated the effect of adenosine administration on caspase-3 (C3) activity and expression during warm renal ischaemia in rat kidney and the role of nitric oxide (NO) as a mediator of the adenosine-induced effect. The following experimental groups were studied: control, ischaemia, ischaemia with adenosine administration, ischaemia with adenosine and N-nitro-L-arginine methyl ester (L-NAME) treatment and ischaemia with NO donor administration. C3 activity was measured and its protein expression determined by Western blot analysis. Supplementation of adenosine or NO during ischaemia increased C3 activity and protein expression but the effect of adenosine was reversed in rats treated with L-NAME. We conclude that adenosine increases C3 activity through an NO-dependent mechanism.
Introduction
Acute renal failure secondary to ischaemia/reperfusion (I/ R) injury is a significant clinical problem. Moreover, renal injury due to I/R leads to impaired renal function and increases the probability of renal failure in organ transplantation [20] . One of the essential pathological changes thereby is cell death due to necrosis and apoptosis [4, 15] , a particular form of cell suicide that leads to the removal of damaged cells by phagocytosis. Brief periods of in vivo ischaemia and renal I/R injury are associated consistently with apoptosis of renal cells [18] . However, the role of factors activating apoptotic events in the kidney is scarcely known because most studies have focused mainly on factors involved in ATP depletion that lead to necrotic cell death rather than to apoptosis.
Caspase-3 (C3) plays a main role in apoptosis as it degrades many key structural and regulatory proteins [8, 9] . C3 activity increases during reperfusion periods, but the mechanism of activation of C3 during ischaemia is still unclear. The exogenous application of adenosine induces cell death by apoptosis in tissues like small intestine or kidney tissue [7, 24] . Recent studies have shown that puromycin aminonucleoside (adenosine plus a puromycin) induces apoptosis in cultured glomerular epithelial cells [22] , but less is known about its effect on programmed cell death in renal tissue. Adenosine stimulates NO production in several systems, including kidney [6, 10, 13, 14] . Moreover, NO induces apoptosis in renal cells [2] . We therefore determined whether adenosine administration influences C3 activity and expression during renal ischaemia in the rat and assessed the role of NO as a mediator of this possible adenosine-induced effect.
Materials and methods

Animals and surgical procedures
The study was performed using male Wistar rats (Ifa Credo, Barcelona, Spain) weighing 250-300 g. The experimental procedures were conducted under the supervision of our institution's Research Commission and followed EU guidelines for handling and care of laboratory animals. The animals were anaesthetised with pentobarbitone sodium (50 mg/kg, Euta-Lender, Madrid, Spain) and placed in a supine position with body temperature maintained at 36-37°C. The abdominal area was covered with saline-soaked gauze at 37°C and a plastic cover to minimise dehydration of exposed tissues. The following experimental groups (n=6 per group) were studied.
1. Control (C): the animals were anaesthetised and laparotomized. 2. Ischaemia (I): the animals were subjected to 60 min of bilateral ischaemia. 3. Ischaemia plus adenosine (I+Ado): the animals underwent the same procedure as group 2 (I) but with administration of adenosine (13.2 mg/kg, i.v. bolus) just before ischaemia. 4. Ischaemia plus adenosine plus N-nitro-L-arginine methyl ester (L-NAME) (I+Ado+NAME): the animals were subjected to the same procedure as the previous group but were also treated with the NO synthase inhibitor L-NAME (10 mg/kg, i.v. bolus) administered 5 min before ischaemia. 5. Ischaemia plus NONOS (I+NONOS): the animals were subjected to 60 min of ischaemia with previous administration of the NO donor N-{4-[1-(3-aminopropyl)-2-hydroxy-2-nitrosohydrazino]butyl}-1,3-propanediamine (spermine NONOate, 10 mg/kg i.v., resuspended in PBS pH=7.4).
To asses the receptor-mediated effect of adenosine, two additional groups were added in which C3 activity was measured.
6. CGS: the animals underwent the same procedure as group 2 (I) but CGS-15943 (an adenosine antagonist, 5 mg/kg, i.v. bolus) was administered 10 min before ischaemia. 7. Ado+CGS: the animals underwent the same procedure as group 3 (I+Ado) but with CGS administration as above.
In all groups, the kidneys were freeze-clamped in vivo, removed and maintained at −80°C until further analysis.
Biochemical analyses
C3 activity
C3-like activity was determined by measuring proteolytic cleavage of the specific substrate N-acetyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin (DEVD-AMC; Biomol, Plymouth Meeting, Pa., USA). Renal tissue was homogenized and sonicated in assay buffer (50 mM HEPES, 10% sucrose, 0.1% CHAPS, 5 mM GSSG, 5 mM DTT). AMC was quantified by fluorospectrophotometry using 380 nm excitation and measurement of emission at 450 nm.
Western blot analysis of cleaved C3
Renal tissue was homogenized and protein content quantified. Aliquots of protein (250 µg/lane) were electrophoresed in 16% SDS-gel and then transferred to nitrocellulose membranes, which were subsequently blocked with 5% non-fat dry milk in 0.06% Tween-TRIS-buffered saline (TTBS) for 1 h. The membranes were incubated overnight with primary antibody (anti C3 at 1:1,000 dilution; Serotec, Oxford, UK) at 4°C, washed 5 times with TTBS and incubated for 1 h with horseradish peroxidase-conjugated antirabbit IgG antibody (dilution 1:5,000) at room temperature, followed by enhanced chemoluminescence (ECL) detection.
TUNEL staining
Renal tissue was embedded in paraffin and cut into 3-µm sections. Slides were deparaffinized. Apoptosis was detected in situ by terminal-deoxynucleotidyl-transferase-mediated deoxyuridine triphosphate nick end labelling (TUNEL) of DNA strand breaks using an in situ cell death detection kit (TdT-FragEL DNA fragmentation detection kit, Oncogene Research Products, Cambridge, Mass., USA) according to the manufacturer's instructions.
NO production
NO production was determined from frozen samples homogenised in 1 ml PBS (pH=7.4) at 4°C by measuring tissue accumulation of nitrite and nitrate using a modification of the method described elsewhere [7] and using a commercial kit (Cayman Chemical, Ann Arbor, Mich., USA).
Protein concentration
Total protein concentration in homogenates was determined using a commercial kit (BioRad, Munich, Germany).
Statistical analysis
All data are expressed as means±SEM. The effects of ischaemia in the different groups were assessed using a one-way ANOVA. The Student-Newman-Keuls test was used to evaluate significant differences between groups, which were assumed to exist when P<0.05.
Results Figure 1 shows the pharmacological modulation of C3-like activity found in this study. The group treated with exogenous adenosine showed an increase in C3 activity. The opposite was the case when the adenosine-treated rats were also given L-NAME to block the effect of NO: C3 activity returned to control values. In contrast, giving NONOS to the ischaemic group significantly increased C3 activity compared with ischaemia alone. The administration of an adenosine receptor antagonist (CGS-15943) in two additional groups decreased C3 activity significantly in ischaemic rats but also reversed the effects of adenosine administration on C3 activity (Table 1) . To confirm the results on C3 activation, Western blot analyses of the cleaved forms (17 kDa and an additional 20-kDa fragment) of the enzyme were made. Similar results were obtained in these two measurements (Fig. 1) . The administration of exogenous adenosine markedly increased the intensity of the cleaved C3 band. The blockage of NO effects by administration of L-NAME to Table 1 Activity of caspase-3, assessed as the cleavage ofN-acetylAsp-Glu-Val-Asp-7-amino-4-methylcoumarin (DEVD-AMC), in rat kidneys under different experimental conditions. Means±SE,n=6 rats/group (C control, I+Ado ischaemia plus adenosine administration, I+CGS ischaemia plus adenosine antagonist CGS-15943, I +Ado+CGS ischaemia plus adenosine plus CGS-15943 administration) adenosine-treated rats decreased this parameter, thus showing a result similar to that found in ischaemic animals. In contrast, the pharmacological administration of NO to ischaemic rats increased the intensity of the cleaved C3 band. Whilst the antibody used recognizes both the 17-kDa (activated caspase) and the intact 32-kDa C3 the intact C3 band was not modified significantly in any of the groups studied. TUNEL staining revealed that groups showing the highest C3-like activity showed also an increase in the number of apoptotic cells (Fig. 2) . Figure 3 shows NO production as reflected by the accumulation of nitrates and nitrites. As expected, exogenous adenosine and NO administration increased NO production. The effect of adenosine administration was prevented by L-NAME.
Discussion
The exact details of controlled cell death pathways are still not fully determined but many biochemical and genetic approaches have established that caspases play an essential role at various stages of the apoptotic process. Overall, apoptosis is considered as an active, energy-requiring process, whereby low ATP levels may result in a failure to activate the apoptotic cascade [16, 19] . The severity and duration of ATP depletion may determine the mechanism of death in lethally injured renal cells. Most studies have focused mainly on the occurrence of apoptosis by factors correlated with the ATP pool but the relationship between apoptosis and changes in other nucleotides has not been investigated so extensively.
In the present study, C3 activity decreased after ischaemia. This finding agrees with decreases previously reported by other authors [18] , but it is contrary to increases reported in other previous studies [20, 22] . We hypothesized that there is a relationship between adenosine administration and C3 activity during warm I/R. Apoptosis probably could not be enhanced during ischaemia if the ATP levels were severely depleted but, apart from ATP, variations in the adenylate catabolic products (e.g. adenosine) could also influence the development of apoptosis. In this respect a recent study has described the effects of adenosine on the induction of apoptosis in glomerular mesangial cells [24] . We found here that supplementation of exogenous adenosine prior to isch-389 Fig. 1 Activity of caspase-3 and Western blot analysis showing the expression of cleaved caspase-3 in kidney after 60 min of ischaemia under different experimental conditions (n=6 rats/group). C control, I ischaemia, I+Ado ischaemia plus adenosine administration, I+Ado +NAME ischaemia plus adenosine plus N-nitro-L-arginine methyl ester administration, I+NONOS ischaemia plus NO donor (spermine NONOate) administration. The expected molecular mass (arrow) is 17-20 kDa. *P<0.05 vs. control Fig. 2A -C TUNEL staining of kidney samples after 60 min of ischaemia under different experimental conditions. A Control; B I+Ado; C I+NONOS (groups as in Fig. 1 ) Fig. 3 NO production (as reflected by production of nitrate plus nitrite, µmol/mg protein) in ischaemic kidneys under different experimental conditions (n=6 rats/group). Groups as in Fig. 1 . *P<0.05 vs. control aemia increased C3 activity and the intensity of the cleaved caspase band, compared with the low C3 activity found in the untreated ischaemic group. The pharmacological blockage of adenosine receptors with CGS-1593 resulted in a lower C3 activity. As far as we are aware, this is the first study describing this relationship between adenosine administration and C3 activity during renal ischaemia. As adenosine is often used in preservation solutions, a plausible effect of exogenous adenosine on apoptosis should not be discounted. Among the different apoptotic indicators, enhanced C3 activity is considered a key criteria for apoptosis [8, 9] ; in agreement, C3 activation resulted in apoptosis enhancement in the groups treated with adenosine or with the NO donor spermine NONOate.
We proposed that adenosine could be related to changes in C3 activity through NO intervention. Adenosine is directly related to NO production [13] and NO is implicated in apoptosis activation. Several studies have shown that NO donors inhibit caspases [11] , presumably by nitrosylating the active site's cysteine. Nevertheless, it has also been reported that treatment with NO donors or forced over-expression of NO synthase inhibit morphological and biochemical apoptotic changes in some systems [11] or induce apoptosis in other experimental models [1] . NO can, therefore, be either pro-or antiapoptotic, depending on its local concentration and cell type. Its proapoptotic effects seem to be linked to pathophysiological conditions, in which high amounts of NO are produced by the inducible NO synthase (NOS). Thus, NO has a direct effect on proteins in the mitochondria, resulting in the release of cytochrome c, caspase activation, and apoptosis. The factors affecting NOmediated caspase activation can be associated with the redox state, transition metal complexes within cells, and the expression of antiapoptotic genes. Therefore, the threshold of NO level that induces caspase activation differs from one cell to another.
In accordance with previous studies [13] , adenosine enhanced NO release. Moreover, the addition of L-NAME, an NOS inhibitor, counteracted the effect of adenosine on C3 activity and expression. These findings thus suggest that NO acts as a mediator of the adenosineinduced activation of C3 during renal ischaemia in the rat kidney. Further support for the role of NO comes from the fact that treating rats with the NO donor NONOS before ischaemia prevented the ischaemia-related decrease of C3 activity. Future studies should aim to define the complete pathway of this adenosine-NO mediated effect on C3 activation and the activity of other caspases, as well as its overall impact on the final apoptotic events. The present findings agree with previous studies which have found a similar adenosine-mediated increase of apoptosis in intestinal cells [3, 7, 23] , astrocytes [5] , heart cells [17, 21] or in glomerular mesangial cells [24] , but differs from another study in which the adenosine-mediated effect inhibited apoptosis in Jurkat T-cells of the immune system [12] .
Nevertheless, the role of adenosine as a blood pressure regulator and the effect of L-NAME in antagonising these haemodynamic effects could suggest that the observed effects on C3 activity could be mediated by haemodynamic changes which were not addressed in our experiments. Therefore, future studies should ascertain whether the observed effects were direct or indirect due to altered renal haemodynamics.
In conclusion, this study shows that exogenous adenosine administration increased C3 activity through a NOdependent mechanism since inhibition of NO synthase by L-NAME reversed the effects of adenosine supplementation.
